Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications

The understanding of G-protein coupled receptors (GPCRs) is undergoing a revolution due to increased information about their signaling and the experimental determination of structures for more than 25 receptors. The availability of at least one receptor structure for each of the GPCR classes, well separated in sequence space, enables an integrated superfamily-wide analysis to identify signatures involving the role of conserved residues, conserved contacts, and downstream signaling in the context of receptor structures. In this study, we align the transmembrane (TM) domains of all experimental GPCR structures to maximize the conserved inter-helical contacts. The resulting superfamily-wide GpcR Sequence-Structure (GRoSS) alignment of the TM domains for all human GPCR sequences is sufficient to generate a phylogenetic tree that correctly distinguishes all different GPCR classes, suggesting that the class-level differences in the GPCR superfamily are encoded at least partly in the TM domains. The inter-helical contacts conserved across all GPCR classes describe the evolutionarily conserved GPCR structural fold. The corresponding structural alignment of the inactive and active conformations, available for a few GPCRs, identifies activation hot-spot residues in the TM domains that get rewired upon activation. Many GPCR mutations, known to alter receptor signaling and cause disease, are located at these conserved contact and activation hot-spot residue positions. The GRoSS alignment places the chemosensory receptor subfamilies for bitter taste (TAS2R) and pheromones (Vomeronasal, VN1R) in the rhodopsin family, known to contain the chemosensory olfactory receptor subfamily. The GRoSS alignment also enables the quantification of the structural variability in the TM regions of experimental structures, useful for homology modeling and structure prediction of receptors. Furthermore, this alignment identifies structurally and functionally important residues in all human GPCRs. These residues can be used to make testable hypotheses about the structural basis of receptor function and about the molecular basis of disease-associated single nucleotide polymorphisms.

[1]  Vadim Cherezov,et al.  Serial Femtosecond Crystallography of G Protein-Coupled Receptors. , 2018, Annual review of biophysics.

[2]  Bas Vroling,et al.  GPCRdb: an information system for G protein-coupled receptors , 2015, Nucleic Acids Res..

[3]  Gianluigi Caltabiano,et al.  GPCRtm: An amino acid substitution matrix for the transmembrane region of class A G Protein-Coupled Receptors , 2015, BMC Bioinformatics.

[4]  Jesús Giraldo,et al.  Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism , 2015, BMC Bioinformatics.

[5]  Henrik G. Dohlman,et al.  Buried ionizable networks are an ancient hallmark of G protein-coupled receptor activation , 2015, Proceedings of the National Academy of Sciences.

[6]  Steffen Wolf,et al.  Sequence, Structure and Ligand Binding Evolution of Rhodopsin-Like G Protein-Coupled Receptors: A Crystal Structure-Based Phylogenetic Analysis , 2015, PloS one.

[7]  Gebhard F. X. Schertler,et al.  GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1–2 September 2014 , 2015, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  The Uniprot Consortium,et al.  UniProt: a hub for protein information , 2014, Nucleic Acids Res..

[9]  Garth J. Williams,et al.  Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser , 2014, Nature.

[10]  Chris de Graaf,et al.  Generic GPCR residue numbers - aligning topology maps while minding the gaps. , 2015, Trends in pharmacological sciences.

[11]  Bartosz Trzaskowski,et al.  Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor , 2014, Proceedings of the National Academy of Sciences.

[12]  Ruben Abagyan,et al.  Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges. , 2014, Structure.

[13]  Tilman Flock,et al.  Structured and disordered facets of the GPCR fold. , 2014, Current opinion in structural biology.

[14]  A. Doré,et al.  Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain , 2014, Nature.

[15]  Vadim Cherezov,et al.  Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs , 2014, Nature Communications.

[16]  Steven M. Moss,et al.  Structure of the human P2Y12 receptor in complex with an antithrombotic drug , 2014, Nature.

[17]  Jens Meiler,et al.  Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator , 2014, Science.

[18]  B. Kobilka,et al.  The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin. , 2014, Current opinion in cell biology.

[19]  M. Zalewska,et al.  G protein-coupled receptors: abnormalities in signal transmission, disease states and pharmacotherapy. , 2014, Acta poloniae pharmaceutica.

[20]  Anna Tramontano,et al.  Critical assessment of methods of protein structure prediction (CASP) — round x , 2014, Proteins.

[21]  William A. Goddard,et al.  SuperBiHelix method for predicting the pleiotropic ensemble of G-protein–coupled receptor conformations , 2013, Proceedings of the National Academy of Sciences.

[22]  J. Wess,et al.  Activation and allosteric modulation of a muscarinic acetylcholine receptor , 2013, Nature.

[23]  Hualiang Jiang,et al.  Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex , 2013, Science.

[24]  S. Garland.  Are GPCRs Still a Source of New Targets? , 2013, Journal of biomolecular screening.

[25]  Caitlin E. Scott,et al.  Computationally‐predicted CB1 cannabinoid receptor mutants show distinct patterns of salt‐bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding , 2013, Proteins.

[26]  Chris de Graaf,et al.  Structure of the human glucagon class B G-protein-coupled receptor , 2013, Nature.

[27]  Ali Jazayeri,et al.  Structure of class B GPCR corticotropin-releasing factor receptor 1 , 2013, Nature.

[28]  Bryan L. Roth,et al.  Structure of the human smoothened receptor bound to an antitumour agent , 2013, Nature.

[29]  Hualiang Jiang,et al.  Structural Basis for Molecular Recognition at Serotonin Receptors , 2013, Science.

[30]  Arthur Christopoulos,et al.  Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations , 2013, Proceedings of the National Academy of Sciences.

[31]  Pawel Pasznik,et al.  Towards Improved Quality of GPCR Models by Usage of Multiple Templates and Profile-Profile Comparison , 2013, PloS one.

[32]  M. Babu,et al.  Molecular signatures of G-protein-coupled receptors , 2013, Nature.

[33]  Caitlin E. Scott,et al.  Molecular basis for dramatic changes in cannabinoid CB1 G protein‐coupled receptor activation upon single and double point mutations , 2013, Protein science : a publication of the Protein Society.

[34]  Joanna L. Sharman,et al.  IUPHAR-DB: updated database content and new features , 2012, Nucleic Acids Res..

[35]  Ruben Abagyan,et al.  The GPCR Network: a large-scale collaboration to determine human GPCR structure and function , 2012, Nature Reviews Drug Discovery.

[36]  W. Goddard,et al.  Conformational ensemble view of G protein-coupled receptors and the effect of mutations and ligand binding. , 2013, Methods in enzymology.

[37]  Cheng Zhang,et al.  High-resolution Crystal Structure of Human Protease-activated Receptor 1 Bound to the Antagonist Vorapaxar Hhs Public Access , 2022 .

[38]  J. Shiloach,et al.  Structure of the agonist-bound neurotensin receptor , 2012, Nature.

[39]  T. Schöneberg,et al.  Using ortholog sequence data to predict the functional relevance of mutations in G‐protein‐coupled receptors , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  Aashish Manglik,et al.  Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.

[41]  Bryan L. Roth,et al.  Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.

[42]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[43]  Albert C. Pan,et al.  Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor , 2012, Nature.

[44]  Hugh Rosen,et al.  Crystal Structure of a Lipid G Protein–Coupled Receptor , 2012, Science.

[45]  Bryan L. Roth,et al.  Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.

[46]  A. Biegert,et al.  HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment , 2011, Nature Methods.

[47]  M. S. Almén,et al.  The Origin of GPCRs: Identification of Mammalian like Rhodopsin, Adhesion, Glutamate and Frizzled GPCRs in Fungi , 2012, PloS one.

[48]  A. Kruse,et al.  Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.

[49]  Ron O. Dror,et al.  High-resolution crystal structure of human Protease-Activated Receptor 1 bound to the antagonist vorapaxar , 2012, Nature.

[50]  W. Goddard,et al.  Characterizing and predicting the functional and conformational diversity of seven-transmembrane proteins. , 2011, Methods.

[51]  T. Lovenberg,et al.  Study of GPR81, the Lactate Receptor, from Distant Species Identifies Residues and Motifs Critical for GPR81 Functions , 2011, Molecular Pharmacology.

[52]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[53]  Virgil L. Woods,et al.  Conformational changes in the G protein Gs induced by the β2 adrenergic receptor , 2011, Nature.

[54]  Nisha Singh,et al.  Structural Basis of Activation of Bitter Taste Receptor T2R1 and Comparison with Class A G-protein-coupled Receptors (GPCRs)* , 2011, The Journal of Biological Chemistry.

[55]  Ruben Abagyan,et al.  Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment. , 2011, Structure.

[56]  S. Rasmussen,et al.  Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.

[57]  Ruben Abagyan,et al.  Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.

[58]  W. Goddard,et al.  Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor , 2011, Proteins.

[59]  R. Stevens,et al.  Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.

[60]  Peer Bork,et al.  Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy , 2011, Nucleic Acids Res..

[61]  Oliver P. Ernst,et al.  Crystal structure of metarhodopsin II , 2011, Nature.

[62]  Leszek P. Pryszcz,et al.  MetaPhOrs: orthology and paralogy predictions from multiple phylogenetic evidence using a consistency-based confidence score , 2010, Nucleic acids research.

[63]  Tim A. H. te Beek,et al.  A series of PDB related databases for everyday needs , 2010, Nucleic Acids Res..

[64]  A. Tramontano,et al.  Critical assessment of methods of protein structure prediction (CASP)—round IX , 2011, Proteins.

[65]  Catherine L. Worth,et al.  GPCR-SSFE: A comprehensive database of G-protein-coupled receptor template predictions and homology models , 2011, BMC Bioinformatics.

[66]  T. Kenakin,et al.  The role of conformational ensembles of seven transmembrane receptors in functional selectivity. , 2010, Current opinion in pharmacology.

[67]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[68]  Jonathan A. Javitch,et al.  Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist , 2010, Science.

[69]  Laurence J. Miller,et al.  Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery , 2010, Pharmacological Reviews.

[70]  Catherine L. Worth,et al.  Comparative Sequence and Structural Analyses of G-Protein-Coupled Receptor Crystal Structures and Implications for Molecular Models , 2009, PloS one.

[71]  Charles L. Brooks,et al.  Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 , 2009, Nature Reviews Drug Discovery.

[72]  S. Rasmussen,et al.  The structure and function of G-protein-coupled receptors , 2009, Nature.

[73]  D Baker,et al.  Prediction of membrane protein structures with complex topologies using limited constraints , 2009, Proceedings of the National Academy of Sciences.

[74]  Geoffrey J. Barton,et al.  Jalview Version 2—a multiple sequence alignment editor and analysis workbench , 2009, Bioinform..

[75]  Raymond C Stevens,et al.  Discovery of new GPCR biology: one receptor structure at a time. , 2009, Structure.

[76]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[77]  Gebhard F. X. Schertler,et al.  Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.

[78]  Thomas Bäck,et al.  GPCR NaVa database: natural variants in human G protein‐coupled receptors , 2008, Human mutation.

[79]  Abdelazize Laoui,et al.  Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist. , 2007, Journal of the American Chemical Society.

[80]  R. Stevens,et al.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. , 2007, Science.

[81]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[82]  Andrei L. Lomize,et al.  OPM: Orientations of Proteins in Membranes database , 2006, Bioinform..

[83]  S. Hill,et al.  G‐protein‐coupled receptors: past, present and future , 2006, British journal of pharmacology.

[84]  D. Baker,et al.  Multipass membrane protein structure prediction using Rosetta , 2005, Proteins.

[85]  Robert Fredriksson,et al.  The GRAFS classification system of G-protein coupled receptors in comparative perspective. , 2005, General and comparative endocrinology.

[86]  S. Gitelman,et al.  Nephrogenic syndrome of inappropriate antidiuresis. , 2005, The New England journal of medicine.

[87]  K Henrick,et al.  Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. , 2004, Acta crystallographica. Section D, Biological crystallography.

[88]  R. Lefkowitz.  Historical review: a brief history and personal retrospective of seven-transmembrane receptors. , 2004, Trends in pharmacological sciences.

[89]  S. Wientroub,et al.  A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation. , 2004, The Journal of clinical endocrinology and metabolism.

[90]  O. Lichtarge,et al.  Evolutionary Trace of G Protein-coupled Receptors Reveals Clusters of Residues That Determine Global and Class-specific Functions* , 2004, Journal of Biological Chemistry.

[91]  Manfred Burghammer,et al.  Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.

[92]  G. Hendy,et al.  Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene. , 2003, The Journal of clinical endocrinology and metabolism.

[93]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[94]  L. Prézeau,et al.  Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. , 2003, Pharmacology & therapeutics.

[95]  Gert Vriend,et al.  GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..

[96]  Harel Weinstein,et al.  Three-dimensional representations of G protein-coupled receptor structures and mechanisms. , 2002, Methods in enzymology.

[97]  Øyvind Edvardsen,et al.  tGRAP, the G-protein coupled receptors mutant database , 2002, Nucleic Acids Res..

[98]  A. Krogh,et al.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.

[99]  E. Milgrom,et al.  A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. , 1998, The Journal of clinical investigation.

[100]  E. Brown,et al.  Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor. , 1998, The Journal of clinical endocrinology and metabolism.

[101]  K. Ray,et al.  Sporadic hypoparathyroidism caused by de Novo gain-of-function mutations of the Ca(2+)-sensing receptor. , 1997, The Journal of clinical endocrinology and metabolism.

[102]  J. Sodroski,et al.  HIV-1 Entry and Macrophage Inflammatory Protein-1β-mediated Signaling Are Independent Functions of the Chemokine Receptor CCR5* , 1997, The Journal of Biological Chemistry.

[103]  A. Parfitt,et al.  Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. , 1996, The New England journal of medicine.

[104]  J. Baron,et al.  Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. , 1996, Human molecular genetics.

[105]  H. Jüppner,et al.  A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. , 1995, Science.

[106]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[107]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[108]  Cynthia Wolberger,et al.  Crystal structure of a MAT alpha 2 homeodomain-operator complex suggests a general model for homeodomain-DNA interactions. , 1991, Cell.